A Case of Low Ejection Fraction Unrelated to Anthracycline Therapy: Chemo Tells a Fib
DOI:
https://doi.org/10.17161/kjm.vol16.19669Palabras clave:
Cardio toxicity, chemotherapy-induced cardiomyopathy, atrial fibrillation, anthracycline, cardiomyopathy, anthracycline-induced cardiomyopathy, echocardiography, TTE, CMRMétricas
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Deya Alkhatib, M.D., Kimberly DeCarr, Issa Pour-Ghaz, M.D., Omar Al-Taweel, M.D., Buthainah Alhwarat, M.D., Addison Bond, Tracy Wineinger, MPH, John Alexander, D.O., Sharif Kayali, D.O., Neeraja Yedlapati, M.D., Isaac Rhea, M.D.

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).